Alex Green from the Department of Neurosurgery at the John Radcliffe Hospital in Oxford and Ray Chaudhuri from the NPF Centre of Excellence at Kings College Hospital, London talk about new and novel invasive therapies which could potentially be available in the future for Parkinson’s disease and explain the process of developing new therapies and the importance of clinical trials. They are also joined by Richard Windle, who has Parkinson’s disease, who gives his insights into participating in clinical trials and how important it is for people with Parkinson’s disease to consider entering clinical trials.
This video has been produced by the EPDA (www.epda.eu.com) and provided here with permission.
Share this Video
Related Videos In Parkinson's Disease
Angelo Antonini, EAN 2023: Highlights in Parkinson’s disease
touchNEUROLOGY editorial board member Prof. Angelo Antonini (Padua University Hospital, Italy) provides an overview of his top three most important updates and hot topics from the annual European Academy of Neurology (EAN), July 1–4, 2023, in the field of Parkinson’s disease. He particularly focusses on new insights in early detection of the disease before motor symptoms […]
Highlights from EAN 2023!
Veronica Clark, Parkinson’s Europe: Presidential Update, and the Parkinson’s Manifesto for Europe
The European Parkinson’s Disease Association (EPDA) recently changed its name to Parkinson’s Europe. They are the only European Parkinson’s umbrella organisation and have been working with the global Parkinson’s community for nearly 30 years. As a leading voice for Parkinson’s in Europe, they provide trusted information; advance and share good practices; raise awareness and improve […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!